{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:08:28Z","timestamp":1772208508129,"version":"3.50.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Glyoxalase 1<\/jats:italic> (<jats:italic>GLO1<\/jats:italic>) plays a crucial role in defending against glycation. Single nucleotide polymorphism (SNP) variants in the <jats:italic>GLO1<\/jats:italic> gene may affect gene expression and alter enzyme activity. However, there have been limited studies evaluating the association between <jats:italic>GLO1<\/jats:italic> and diabetes, especially gestational diabetes mellitus (GDM). Therefore, this study is the first to explore the association of <jats:italic>GLO1<\/jats:italic> SNPs and GDM risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study included a total of 500 GDM patients and 502 control subjects. The SNPscan\u2122 genotyping assay was used to genotype rs1781735, rs4746 and rs1130534. To assess the disparities in genotype, allele, and haplotype distributions and their correlation with GDM risk, the independent sample t-test, logistic regression, and chi-square test were employed during the data processing phase. Furthermore, one-way ANOVA was conducted to determine the differences in genotype and blood glucose and methylglyoxal(MG) levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Significant differences were observed in prepregnancy body mass index (pre-BMI), age, systolic blood pressure (SBP), diastolic blood pressure (DBP), and parity between GDM and healthy subjects (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). After adjusting for these factors, <jats:italic>GLO1<\/jats:italic> rs1130534 TA remained associated with an increased risk of GDM (TA <jats:italic>vs<\/jats:italic>. TT + AA: OR = 1.320; 95% CI: 1.008-1.728; <jats:italic>P<\/jats:italic> = 0.044), especially in the pre-BMI \u2265 24 subgroup (TA <jats:italic>vs<\/jats:italic>. TT + AA: OR = 2.424; 95% CI: 1.048-5.607; <jats:italic>P<\/jats:italic> = 0.039), with fasting glucose levels being significantly elevated in the TA genotype compared to the TT genotype (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). Conversely, the <jats:italic>GLO1<\/jats:italic> rs4746 TG was associated with a decreased risk of GDM (TG <jats:italic>vs<\/jats:italic>. TT: OR = 0.740; 95% CI: 0.548-0.999; <jats:italic>P<\/jats:italic> = 0.049; TG <jats:italic>vs<\/jats:italic>. TT + GG: OR = 0.740; 95% CI: 0.548-0.998; <jats:italic>P<\/jats:italic> = 0.048). Additionally, the haplotype T-G-T of rs1781735, rs4746 and rs1130534 was associated with a decreased risk of GDM among individuals with a pre-BMI \u2265 24 (OR = 0.423; 95% CI: 0.188-0.955; <jats:italic>P<\/jats:italic> = 0.038). Furthermore, the rs1781735 GG genotype was found to be more closely related to maternal MG accumulation and neonatal weight gain (<jats:italic>P<\/jats:italic> &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings suggested that <jats:italic>GLO1<\/jats:italic> rs1130534 was associated with an increased susceptibility to GDM and higher blood glucose levels, but <jats:italic>GLO1<\/jats:italic> rs4746 was associated with a decreased risk of GDM. The rs1781735 has been associated with the accumulation of maternal MG and subsequent weight gain in neonates.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1235581","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T14:05:17Z","timestamp":1699020317000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between GLO1 variants and gestational diabetes mellitus susceptibility in a Chinese population: a preliminary study"],"prefix":"10.3389","volume":"14","author":[{"given":"Qiaoli","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengqiong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzhi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runmin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2012.96","article-title":"Gestational diabetes mellitus: risks and management during and after pregnancy","volume":"8","author":"Buchanan","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s40618-016-0607-5","article-title":"Gestational diabetes mellitus: an updated overview","volume":"40","author":"Chiefari","year":"2017","journal-title":"J endocrinological Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/ijmr.IJMR_852_18","article-title":"Risk of type 2 diabetes mellitus after gestational diabetes mellitus: A systematic review & meta-analysis","volume":"154","author":"You","year":"2021","journal-title":"Indian J Med Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195736","article-title":"Gestational diabetes mellitus-recent literature review","volume":"11","author":"Modzelewski","year":"2022","journal-title":"J Clin Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017519","article-title":"Association between polymorphisms in microRNAs and susceptibility to diabetes mellitus: A meta-analysis","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110663","article-title":"Glyoxalase system: A systematic review of its biological activity, related-diseases, screening methods and small molecule regulators","volume":"131","author":"He","year":"2020","journal-title":"Biomed pharmacother"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2011.02.015","article-title":"Glyoxalase in diabetes, obesity and related disorders","volume":"22","author":"Rabbani","year":"2011","journal-title":"Semin Cell Dev Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00001.2019","article-title":"Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases","volume":"100","author":"Schalkwijk","year":"2020","journal-title":"Physiol Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.semcancer.2017.05.006","article-title":"Multiple roles of glyoxalase 1-mediated suppression of methylglyoxal glycation in cancer biology-Involvement in tumour suppression, tumour growth, multidrug resistance and target for chemotherapy","volume":"49","author":"Rabbani","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7424","article-title":"Glyoxalase 1 modulation in obesity and diabetes","volume":"30","author":"Rabbani","year":"2019","journal-title":"Antioxid Redox Signaling"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020415","article-title":"Glyoxalases in urological Malignancies","volume":"19","author":"Antognelli","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122965","article-title":"Glyoxalase-1-dependent methylglyoxal depletion sustains PD-L1 expression in metastatic prostate cancer cells: A novel mechanism in cancer immunosurveillance escape and a potential novel target to overcome PD-L1 blockade resistance","volume":"13","author":"Antognelli","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142358","article-title":"Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels","volume":"316","author":"Saxena","year":"2007","journal-title":"Sci (New York N.Y.)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020219","article-title":"Polymorphisms in glyoxalase I gene are not associated with glyoxalase I expression in whole blood or markers of methylglyoxal stress: the CODAM study","volume":"10","author":"Maasen","year":"2021","journal-title":"Antioxid (Basel Switzerland)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074014","article-title":"Glyoxalase 1-419C>A variant is associated with oxidative stress: implications in prostate cancer progression","volume":"8","author":"Antognelli","year":"2013","journal-title":"PloS One"},{"key":"B16","first-page":"493","article-title":"GLYOXALASE I a111e, paraoxonase 1 q192r and l55m polymorphisms in italian patients with sporadic cerebral cavernous malformations: a pilot study","volume":"29","author":"Rinaldi","year":"2015","journal-title":"J Biol regulators homeostatic Agents"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12040639","article-title":"Clinical implications of glyoxalase1 gene polymorphism and elevated levels of the reactive metabolite methylglyoxal in the susceptibility of type 2 diabetes mellitus in the patients from asir and tabuk regions of Saudi Arabia","volume":"12","author":"Alhujaily","year":"2022","journal-title":"J personalized Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2012.11.009","article-title":"Identification of glyoxalase 1 polymorphisms associated with enzyme activity","volume":"515","author":"Peculis","year":"2013","journal-title":"Gene"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1345124","article-title":"C332C genotype of glyoxalase 1 and its association with late diabetic complications","volume":"121","author":"Groener","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910191","article-title":"Metastatic prostate cancer cells secrete methylglyoxal-derived MG-H1 to reprogram human osteoblasts into a dedifferentiated, Malignant-like phenotype: A possible novel player in prostate cancer bone metastases","volume":"22","author":"Antognelli","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2018.07.013","article-title":"Testosterone and follicle stimulating hormone-dependent glyoxalase 1 up-regulation sustains the viability of porcine sertoli cells through the control of hydroimidazolone- and argpyrimidine-mediated NF-\u03baB pathway","volume":"188","author":"Antognelli","year":"2018","journal-title":"Am J Pathol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.30349","article-title":"Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor","volume":"131","author":"Junaid","year":"2004","journal-title":"Am J Med Genet Part A"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/13524585070130040201","article-title":"Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis","volume":"13","author":"Sidoti","year":"2007","journal-title":"Multiple sclerosis (Houndmills Basingstoke England)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/aur.197","article-title":"Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity\u2013implications for autism","volume":"4","author":"Barua","year":"2011","journal-title":"Autism Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020326","article-title":"Biochemical regulation of the glyoxalase system in response to insulin signaling","volume":"10","author":"Lee","year":"2021","journal-title":"Antioxid (Basel Switzerland)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/db05-0857","article-title":"Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species","volume":"55","author":"Riboulet-Chavey","year":"2006","journal-title":"Diabetes"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1159\/000285845","article-title":"Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients","volume":"33","author":"Kalousov\u00e1","year":"2010","journal-title":"Kidney Blood Pressure Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(00)00874-8","article-title":"Glyoxalase I phenotype as a potential risk factor for prostate carcinoma","volume":"57","author":"Samadi","year":"2001","journal-title":"Urology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-115","article-title":"CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study","volume":"9","author":"Antognelli","year":"2009","journal-title":"BMC Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.739526","article-title":"Glyoxalase 1 confers susceptibility to schizophrenia: from genetic variants to phenotypes of neural function","volume":"14","author":"Yin","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ng.762","article-title":"A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease","volume":"43","author":"Brest","year":"2011","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3132\/dvdr.2004.004","article-title":"Common polymorphisms in the glyoxalase-1 gene and their association with pro-thrombotic factors","volume":"1","author":"Gale","year":"2004","journal-title":"Diabetes Vasc Dis Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/BF01026032","article-title":"A simplified method for the purification of human red blood cell glyoxalase. I. Characteristics, immunoblotting, and inhibitor studies","volume":"12","author":"Allen","year":"1993","journal-title":"J Protein Chem"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1235581\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T14:05:20Z","timestamp":1699020320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1235581\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":33,"alternative-id":["10.3389\/fendo.2023.1235581"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1235581","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"article-number":"1235581"}}